It is not surprising that our follow-up studies revealed that the highly elevated levels of IgG1, IgG3, and total IgG in the IgG aggregates of MS blood serve as biomarkers for MS and for secondary progressive MS [4]. Here, IGHG3 is linked to myeloid sarcoma.